Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.
This study has been completed.
Sponsor:
Pfizer
Information provided by:
Pfizer
ClinicalTrials.gov Identifier:
NCT00239109
First received: October 12, 2005
Last updated: March 17, 2008
Last verified: March 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | February 2007 |
| Estimated Primary Completion Date: | No date given |